Protective Efficacy of a Global HIV-1 Mosaic Vaccine against Heterologous SHIV Challenges in Rhesus Monkeys

被引:295
作者
Barouch, Dan H. [1 ,2 ]
Stephenson, Kathryn E. [1 ]
Borducchi, Erica N. [1 ]
Smith, Kaitlin [1 ]
Stanley, Kelly [1 ]
McNally, Anna G. [1 ]
Liu, Jinyan [1 ]
Abbink, Peter [1 ]
Maxfield, Lori F. [1 ]
Seaman, Michael S. [1 ]
Dugast, Anne-Sophie [2 ]
Alter, Galit [2 ]
Ferguson, Melissa [3 ]
Li, Wenjun [4 ]
Earl, Patricia L. [5 ]
Moss, Bernard [5 ]
Giorgi, Elena E. [6 ]
Szinger, James J. [6 ]
Eller, Leigh Anne [7 ]
Billings, Erik A. [7 ]
Rao, Mangala [7 ]
Tovanabutra, Sodsai [7 ]
Sanders-Buell, Eric [7 ]
Weijtens, Mo [8 ]
Pau, Maria G. [8 ]
Schuitemaker, Hanneke [8 ]
Robb, Merlin L. [7 ]
Kim, Jerome H. [7 ]
Korber, Bette T. [6 ]
Michael, Nelson L. [7 ]
机构
[1] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Ctr Virol & Vaccine Res, Boston, MA 02215 USA
[2] Ragon Inst MGH Massachusetts Inst Technol & Harva, Boston, MA 02114 USA
[3] Alpha Genesis Inc, Yemassee, SC 29945 USA
[4] Univ Massachusetts, Sch Med, Worcester, MA 01605 USA
[5] NIAID, Bethesda, MD 20892 USA
[6] Los Alamos Natl Lab, Los Alamos, NM 87545 USA
[7] Walter Reed Army Inst Res, US Mil HIV Res Program, Rockville, MD 20850 USA
[8] Crucell Holland BV, NL-2301 CA Leiden, Netherlands
基金
美国国家卫生研究院;
关键词
SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTE RESPONSES; IMMUNE CONTROL; BREADTH; AIDS; IMMUNOGENICITY; DIVERSITY; INFECTION; MACAQUES; COVERAGE;
D O I
10.1016/j.cell.2013.09.061
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The global diversity of HIV-1 represents a critical challenge facing HIV-1 vaccine development. HIV-1 mosaic antigens are bioinformatically optimized immunogens designed for improved coverage of HIV-1 diversity. However, the protective efficacy of such global HIV-1 vaccine antigens has not previously been evaluated. Here, we demonstrate the capacity of bivalent HIV-1 mosaic antigens to protect rhesus monkeys against acquisition of infection following heterologous challenges with the difficult-to-neutralize simian-human immunodeficiency virus SHIV-SF162P3. Adenovirus/poxvirus and adenovirus/adenovirus vector-based vaccines expressing HIV-1 mosaic Env, Gag, and Pol afforded a significant reduction in the per-exposure acquisition risk following repetitive, intrarectal SHIV-SF162P3 challenges. Protection against acquisition of infection correlated with vaccine-elicited binding, neutralizing, and functional nonneutralizing antibodies, suggesting that the coordinated activity of multiple antibody functions may contribute to protection against difficult-to-neutralize viruses. These data demonstrate the protective efficacy of HIV-1 mosaic antigens and suggest a potential strategy for the development of a global HIV-1 vaccine.
引用
收藏
页码:531 / 539
页数:9
相关论文
共 37 条
  • [1] Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D
    Abbink, Peter
    Lemckert, Angelique A. C.
    Ewald, Bonnie A.
    Lynch, Diana M.
    Denholtz, Matthew
    Smits, Shirley
    Holterman, Lennart
    Damen, Irma
    Vogels, Ronald
    Thorner, Anna R.
    O'Brien, Kara L.
    Carville, Angela
    Mansfield, Keith G.
    Goudsmit, Jaap
    Havenga, Menzo J. E.
    Barouch, Dan H.
    [J]. JOURNAL OF VIROLOGY, 2007, 81 (09) : 4654 - 4663
  • [2] A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples
    Ackerman, Margaret E.
    Moldt, Brian
    Wyatt, Richard T.
    Dugast, Anne-Sophie
    McAndrew, Elizabeth
    Tsoukas, Stephen
    Jost, Stephanie
    Berger, Christoph T.
    Sciaranghella, Gaia
    Liu, Qingquan
    Irvine, Darrell J.
    Burton, Dennis R.
    Alter, Galit
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 2011, 366 (1-2) : 8 - 19
  • [3] Antibody-Mediated Protection against Mucosal Simian-Human Immunodeficiency Virus Challenge of Macaques Immunized with Alphavirus Replicon Particles and Boosted with Trimeric Envelope Glycoprotein in MF59 Adjuvant
    Barnett, Susan W.
    Burke, Brian
    Sun, Yide
    Kan, Elaine
    Legg, Harold
    Lian, Ying
    Bost, Kristen
    Zhou, Fengmin
    Goodsell, Amanda
    zur Megede, Jan
    Polo, John
    Donnelly, John
    Ulmer, Jeffrey
    Otten, Gillis R.
    Miller, Christopher J.
    Vajdy, Michael
    Srivastava, Indresh K.
    [J]. JOURNAL OF VIROLOGY, 2010, 84 (12) : 5975 - 5985
  • [4] Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope
    Barnetta, Susan W.
    Srivastava, Indresh K.
    Kan, Elaine
    Zhou, Fengmin
    Goodsell, Amanda
    Cristillo, Anthony D.
    Ferrai, Maria Grazia
    Weiss, Deborah E.
    Letvin, Norman L.
    Montefiori, David
    Pal, Ranajit
    Vajdy, Michael
    [J]. AIDS, 2008, 22 (03) : 339 - 348
  • [5] Challenges in the development of an HIV-1 vaccine
    Barouch, Dan H.
    [J]. NATURE, 2008, 455 (7213) : 613 - 619
  • [6] Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys
    Barouch, Dan H.
    Liu, Jinyan
    Li, Hualin
    Maxfield, Lori F.
    Abbink, Peter
    Lynch, Diana M.
    Iampietro, M. Justin
    SanMiguel, Adam
    Seaman, Michael S.
    Ferrari, Guido
    Forthal, Donald N.
    Ourmanov, Ilnour
    Hirsch, Vanessa M.
    Carville, Angela
    Mansfield, Keith G.
    Stablein, Donald
    Pau, Maria G.
    Schuitemaker, Hanneke
    Sadoff, Jerald C.
    Billings, Erik A.
    Rao, Mangala
    Robb, Merlin L.
    Kim, Jerome H.
    Marovich, Mary A.
    Goudsmit, Jaap
    Michael, Nelson L.
    [J]. NATURE, 2012, 482 (7383) : 89 - U115
  • [7] Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys
    Barouch, Dan H.
    O'Brien, Kara L.
    Simmons, Nathaniel L.
    King, Sharon L.
    Abbink, Peter
    Maxfield, Lori F.
    Sun, Ying-Hua
    La Porte, Annalena
    Riggs, Ambryice M.
    Lynch, Diana M.
    Clark, Sarah L.
    Backus, Katherine
    Perry, James R.
    Seaman, Michael S.
    Carville, Angela
    Mansfield, Keith G.
    Szinger, James J.
    Fischer, Will
    Muldoon, Mark
    Korber, Bette
    [J]. NATURE MEDICINE, 2010, 16 (03) : 319 - U116
  • [8] Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox
    Earl, PL
    Americo, JL
    Wyatt, LS
    Eller, LA
    Whitbeck, JC
    Cohen, GH
    Eisenberg, RJ
    Hartmann, CJ
    Jackson, DL
    Kulesh, DA
    Martinez, MJ
    Miller, DM
    Mucker, EM
    Shamblin, JD
    Zwiers, SH
    Huggins, JW
    Jahrling, PB
    Moss, B
    [J]. NATURE, 2004, 428 (6979) : 182 - 185
  • [9] Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants
    Fischer, Will
    Perkins, Simon
    Theiler, James
    Bhattacharya, Tanmoy
    Yusim, Karina
    Funkhouser, Robert
    Kuiken, Carla
    Haynes, Barton
    Letvin, Norman L.
    Walker, Bruce D.
    Hahn, Beatrice H.
    Korber, Bette T.
    [J]. NATURE MEDICINE, 2007, 13 (01) : 100 - 106
  • [10] Distinct Evolutionary Pressures Underlie Diversity in Simian Immunodeficiency Virus and Human Immunodeficiency Virus Lineages
    Fischer, Will
    Apetrei, Cristian
    Santiago, Mario L.
    Li, Yingying
    Gautam, Rajeev
    Pandrea, Ivona
    Shaw, George M.
    Hahn, Beatrice H.
    Letvin, Norman L.
    Nabel, Gary J.
    Korber, Bette T.
    [J]. JOURNAL OF VIROLOGY, 2012, 86 (24) : 13217 - 13231